Day 1
Opening Ceremony - Hon. Dr. Tinte Itinteang, Minister of Health and Medical Services - Kiribati [Keynote Speaker]
Session 1 - Maria Dutarte, Executive Director, European Patients’ Academy on Therapeutic Innovation (EUPATI)
Session 1 - Tony Holland, Board Member, International Alliance of Patients’ Organizations (IAPO) & President, International Prader-Willi Syndrome Organisation (IPWSO)
Session 2 - Dr Catherine Duggan, Chief Executive Officer, International Pharmaceutical Federation
Session 2 - Dr Osahon Enabulele, President, World Medical Association
Session 2 - Howard Catton, Chief Executive Officer, International Council Nurses
Session 2 - Prof Lara Bloom, Board Member, International Alliance of Patients’ Organizations (IAPO) & President and CEO, The Ehlers-Danlos Society
Session 2 - Rod Padua, Strategic Advisor and Council Member, Alliance & Partnerships for Patient Innovation & Solutions (APPIS)
Session 2 - Paul Mendonza, Board Member, International Alliance of Patients’ Organizations (IAPO) & President, Psoriasis Philippines
Session 3 - Dr Sawsan A. AlMadhi, Advocacy Advisor, CEO & Founder, AlignnEficient Health Consultancies CO LLC
Session 3 - Dr Maira Caleffi, MD PhD, IEEPO External Advisory Committee Member
Session 4 - Ana Elisa M. Barbar, Adviser to the Health Unit - Health Care in Danger Initiative, International Committee of the Red Cross (ICRC)
Session 4 - Dr Luis Castrillo, Past-president & Co-chair of the EM-Day Workgroup & Member of the Wellbeing Group, European Society for Emergency Medicine (EUSEM)
Session 4 - Dr Neda Milevska-Kostova, Chair, International Alliance of Patients’ Organizations (IAPO) & President, IAPO Patients for Patient Safety Observatory
Session 4 - Dr Neelam Dhingra, Head, Patient Safety Flagship: A Decade of Patient Safety 2021-2030, World Health Organization
Day 2
Session 5 - Dr Lembit Rägo, Secretary-General, Council for International Organizations of Medical Sciences (CIOMS)
Session 5 - Dr Maria Mavris, PhD, Public and Stakeholder Engagement Department - Stakeholders and Communication Division, European Medicines Agency (EMA)
Session 5 - Marie Valentin, Technical Officer, Regulatory Convergence and Networks Team, World Health Organization
Session 5 - Janis Bernat, Director, Scientific & Regulatory Affairs, International Federation of Pharmaceutical Manufacturers Association (IFPMA)
Session 6 - Agron Bytyqi, Chairman of the Board, Patients’ Rights Association in Kosovo - PRAK
Session 6 - Dr Konstantinos Antypas, Research Manager, SINTEF Digital & Senior Researcher, Norwegian Centre for E-health Research
Session 6 - Judy Stenmark, Director General, Global Self-Care Federation
Session 6 - Raymond Anderson, Past President & Trustee of Commonwealth Pharmacists Association
Session 6 - Fatima Seedat, Development Manager, The South African Depression & Anxiety Group (SADAG) VIDEO
Session 7 - Diego Fernando Gil Cardozo, Executive Director, Colombian Federation of Rare Diseases - FECOER
Session 7 - Dr Dalia Dawoud, Associate Director (Research), Science, Policy and Research Programme, National Institute for Health and Care Excellence (NICE)
Session 7 - Dr Paula Blancarte Jaber, Project Manager - Outcomes Research Team, International Consortium for Health Outcomes Measurement (ICHOM)
Session 7 - Orajitt Bumrungskulswat, Board Member, International Alliance of Patients’ Organizations (IAPO) & Assistant Secretary General, Heart to Heart Foundation
English
Español